Related Experiment Videos
[Esophagectomy without thoracotomy. Comparison between a retrospective study and a prospective randomized trial]
B Launois1, D Khelif, B Meunier
1Centre de Chirurgie digestive et Unité de Transplantation, Hôpital Pontchaillou, CHU de Rennes.
Chirurgie; Memoires De L'Academie De Chirurgie
|January 1, 1994
Summary
Minimally invasive esophagectomy without thoracotomy is a viable option for patients with contraindications. Survival outcomes depend on cancer stage, not surgical approach.
Area of Science:
- Surgical Oncology
- Thoracic Surgery
- Gastrointestinal Surgery
Background:
- Esophagectomy is a critical procedure for esophageal cancer.
- Thoracotomy-based approaches carry significant risks, especially for comorbid patients.
- Alternative minimally invasive techniques are being explored to improve patient outcomes.
Purpose of the Study:
- To evaluate the outcomes of esophagectomy performed without thoracotomy.
- To compare the safety and efficacy of this approach against traditional methods.
- To identify factors influencing survival in patients undergoing esophagectomy without thoracotomy.
Main Methods:
- Retrospective analysis of 96 esophagectomies performed without thoracotomy between 1983 and 1989.
- Patient selection criteria included age, respiratory disease, heart disease, and superficial lesions.
- Comparison with a prospective randomized study evaluating different surgical approaches.
Main Results:
- Operative mortality was 3.1% and anastomotic fistulization occurred in 7.5% of cases.
- Five-year actuarial survival was 29%, influenced by tumor stage, size, invasion, and TNM classification, but not age.
- A comparative study showed similar mortality and complication rates between esophagectomy with and without thoracotomy.
Conclusions:
- Esophagectomy without thoracotomy is a safe alternative for selected patients, particularly those with contraindications.
- Surgical approach (with or without thoracotomy) does not significantly impact long-term survival.
- Disease stage remains the most critical determinant of long-term survival in esophageal cancer patients.